ORAMED PHARMACEUTICALS INC. Quarterly Common Stock, Shares, Outstanding from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Oramed Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2011 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 40.6M shares, a 1.02% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 40.6M +410K +1.02% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 40.5M +549K +1.37% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 40.3M +775K +1.96% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 40.3M +1.17M +2.99% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 40.2M +1.66M +4.29% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 40M +1.41M +3.65% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 39.6M +1.41M +3.68% Dec 31, 2022 10-K 2024-03-06
Q3 2022 39.1M +3.82M +10.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 38.6M +8.04M +26.3% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 38.6M +10.3M +36.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 38.2M +14.3M +60.3% Dec 31, 2021 10-K 2023-03-06
Q3 2021 35.3M +11.6M +49.1% Aug 31, 2021 10-QT 2022-03-30
Q2 2021 30.5M +7.25M +31.1% May 31, 2021 10-Q 2021-07-14
Q1 2021 28.3M +5.2M +22.5% Feb 28, 2021 10-Q 2021-04-13
Q4 2020 23.8M +6.41M +36.8% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 23.7M +6.29M +36.2% Aug 31, 2020 10-K 2021-11-24
Q2 2020 23.3M +5.89M +33.9% May 31, 2020 10-Q 2020-07-07
Q1 2020 23.1M +5.71M +32.9% Feb 29, 2020 10-Q 2020-04-06
Q4 2019 17.4M +22.3K +0.13% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 17.4M +13.5K +0.08% Aug 31, 2019 10-K 2020-11-24
Q2 2019 17.4M +2.91M +20.1% May 31, 2019 10-Q 2019-07-10
Q1 2019 17.4M +2.97M +20.7% Feb 28, 2019 10-Q 2019-04-10
Q4 2018 17.4M +3.07M +21.5% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 17.4M +3.7M +27.1% Aug 31, 2018 10-K 2019-11-27
Q2 2018 14.5M +1.15M +8.63% May 31, 2018 10-Q 2018-07-12
Q1 2018 14.4M +1.11M +8.38% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 14.3M +1.04M +7.84% Nov 30, 2017 10-Q 2018-01-11
Q3 2017 13.7M +485K +3.68% Aug 31, 2017 10-K 2018-11-28
Q2 2017 13.3M +188K +1.43% May 31, 2017 10-Q 2017-07-06
Q1 2017 13.3M +182K +1.39% Feb 28, 2017 10-Q 2017-04-05
Q4 2016 13.3M +1.67M +14.4% Nov 30, 2016 10-Q 2017-01-11
Q3 2016 13.2M +1.62M +14% Aug 31, 2016 10-K 2017-11-29
Q2 2016 13.1M +2.29M +21.2% May 31, 2016 10-Q 2016-07-06
Q1 2016 13.1M +2.29M +21.2% Feb 29, 2016 10-Q 2016-04-06
Q4 2015 11.6M +790K +7.31% Nov 30, 2015 10-Q 2016-01-13
Q3 2015 11.6M +1.46M +14.5% Aug 31, 2015 10-K 2016-11-25
Q2 2015 10.8M +881K +8.85% May 31, 2015 10-Q 2015-07-01
Q1 2015 10.8M +1.04M +10.7% Feb 28, 2015 10-Q 2015-04-03
Q4 2014 10.8M +2.86M +36% Nov 30, 2014 10-Q 2015-01-08
Q3 2014 10.1M +2.16M +27.3% Aug 31, 2014 10-K 2015-11-25
Q2 2014 9.96M +2.73M +37.8% May 31, 2014 10-Q 2014-07-14
Q1 2014 9.78M +2.55M +35.4% Feb 28, 2014 10-Q 2014-04-10
Q4 2013 7.95M +748K +10.4% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 7.94M +1.26M +18.9% Aug 31, 2013 10-K 2014-11-14
Q2 2013 7.23M -63.2M -89.7% May 31, 2013 10-Q 2013-07-17
Q1 2013 7.22M -63M -89.7% Feb 28, 2013 10-Q 2013-04-11
Q4 2012 7.2M -62.9M -89.7% Jan 10, 2013 10-Q 2014-04-10
Q3 2012 6.67M -63.4M -90.5% Aug 31, 2012 10-K 2013-11-27
Q2 2012 70.4M May 31, 2012 10-Q 2012-07-12
Q1 2012 70.2M Feb 29, 2012 10-Q 2012-04-04
Q4 2011 70.1M Nov 30, 2011 10-Q 2012-01-12
Q3 2011 70.1M Aug 31, 2011 10-K 2012-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.